Summary of Significant Accounting Policies - Additional Information (Details)	1 Months Ended	12 Months Ended
	Dec. 31, 2023 USD ($) shares	Dec. 31, 2023 USD ($) director vendor segment employee consultant shares	Dec. 31, 2022 USD ($) shares
Accounting Policies [Line Items]
Restricted cash	$ 4,267	$ 4,267	$ 49,260
Tangible asset impairment		0
In-Process R&D Impairment		1,904,314	0
Business combination, finite-lived intangibles	8,700,000	$ 8,700,000	10,600,000
Business segment | segment		1
Geographic segments | segment		3
Deferred tax liabilities, net	779,440	$ 779,440	689,121
Unrecognized uncertain income tax	0	0	0
Tax receivable	$ 1,900,000	$ 1,900,000	$ 1,300,000
Unvested restricted common stock (in shares) | shares	229,373	229,373	30,000
Related party transactions, number of vendors | vendor		1
Related party transactions, number of employees | employee		3
Related party transactions, number of consultants | consultant		15
In-process R&D, fair value	$ 8,700,000	$ 8,700,000	$ 10,600,000
Consultant advisory services
Accounting Policies [Line Items]
Expenses from transactions with related party		500,000
Employment related costs
Accounting Policies [Line Items]
Expenses from transactions with related party	100,000
Ora, Inc | Clinical study services
Accounting Policies [Line Items]
Expenses from transactions with related party		$ 100,000
Related party transactions, number of directors | director		1
Bayon | Milestone payments to former shareholders
Accounting Policies [Line Items]
Expenses from transactions with related party	$ 500,000
Minimum
Accounting Policies [Line Items]
Estimated useful life (Years)	2 years	2 years
Maximum
Accounting Policies [Line Items]
Estimated useful life (Years)	5 years	5 years